Search
for
Sort by
Research 30 of 158
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Dermatological medications and local therapeutics
- “Burning scalp” syndrome: relevance, place in clinical taxonomy and therapeutic approaches
- Dermatite atópica em uma cadela: Caso clínico
- Effect of Madayantika Siddha Taila in Darunaka W.S.R. to Seborrhea Capitis
- Treatment of pseudofolliculitis in trichotillomania improves outcome
- VII International Congress, Asociación Dermatológica del Caribe (Dermocaribe), Cartagena de Indias, Colombia, March 17-20, 2011
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Dermatoses of pregnancy
- Safety of dermatologic medications in pregnancy and lactation
- Physiologic changes and dermatoses of pregnancy
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Skin eruptions specific to pregnancy: an overview
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Update on psychodermatological disorders
- Atlas of Geriatric Dermatology
- A guide to cost-effective emollient prescribing
- Hypersensitivity Diseases
- Index
- Herbal Therapy in Dermatology
- Wound Healing and the Use of Medicinal Plants
- Physiologic skin changes in pregnancy
- Effects of Turmeric (<i>Curcuma longa</i>) on Skin Health: A Systematic Review of the Clinical Evidence
- Drug-Induced Skin, Nail and Hair Disorders
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Niosomes as a propitious carrier for topical drug delivery
- Management of congenital ichthyoses: European guidelines of care, part two
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors